Follow The Filings

ENTG Entegris Inc.

Information Technology, filed as ENTEGRIS INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 5

  • #277
  • Master 0.02%
  • 1 exit

In 2026 Q3 Torray Investment Partners sold out of Entegris.

Who owns ENTG

Sorted by value, long equity only, as of 2026 Q3.

History
Torray Investment Partners exited 2026 Q3 Last 2026 Q2 0.44% Exit −0.44% 18,001 $3.2M History

0 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ENTG's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ENTG insider trades
  • None no insider bought on the open market
  • $11M sold by 6 insiders outside a trading plan
  • $40.1M sold by 4 insiders under 10b5-1 plans
  1. Olivier Blachier President, Materials Solutions
    Planned sale
    $321K 2,000 shares at $160.66 5.4% of stake
    Traded Aug 14 Filed Aug 17
    ↗
  2. Joseph Colella SVP and General Counsel
    Sale
    $644K 3,916 shares at $164.48 7.2% of stake
    Traded Aug 13 Filed Aug 14
    ↗
  3. Susan G. Rice SVP, Global Human Resources
    Sale
    $308K 2,062 shares at $149.52 3% of stake
    Traded Aug 11 Filed Aug 12
    ↗
  4. James P Lederer Director
    Sale
    $512K 3,569 shares at $143.59 16% of stake
    Traded Jun 3 Filed Jun 4
    ↗
  5. Clinton M. Haris SVP & President, APS Division
    Planned sale
    $1M 6,848 shares at $149.23 11% of stake
    Traded May 27 Filed May 28
    ↗
  6. Susan G. Rice SVP, Global Human Resources
    Sale
    $2.6M 19,893 shares at $132.84 22% of stake
    Traded May 15 Filed May 18
    ↗
  7. Olivier Blachier SVP, Chief Strategy Officer
    Sale
    $280K 2,000 shares at $140.04 5.4% of stake
    Traded May 14 Filed May 18
    ↗
  8. Joseph Colella SVP and General Counsel
    Sale
    $887K 6,326 shares at $140.17 11% of stake
    Traded May 14 Filed May 18
    ↗
  9. Clinton M. Haris SVP & President, APS Division
    Planned sale
    $843K 5,830 shares at $144.57 9.6% of stake
    Traded May 14 Filed May 18
    ↗
  10. Bertrand Loy Chair
    Planned sale
    $6.4M 44,138 shares at $144.41 16% of stake
    Traded Apr 17 Filed Apr 20
    ↗
  11. Bertrand Loy Chair
    Planned sale
    $2.4M 17,396 shares at $140.22 7.1% of stake
    Traded Apr 14 Filed Apr 16
    ↗
  12. Olivier Blachier SVP, Chief Strategy Officer
    Planned sale
    $32K 275 shares at $115.57 0.8% of stake
    Traded Apr 7 Filed Apr 8
    ↗
  13. Joseph Colella SVP and General Counsel
    Planned sale
    $184K 1,592 shares at $115.57 3.1% of stake
    Traded Apr 7 Filed Apr 8
    ↗
  14. Bertrand Loy Chair
    Planned sale
    $15.2M 109,838 shares at $138.25 34% of stake
    Traded Feb 24–25 Filed Feb 26
    ↗
  15. Joseph Colella SVP and General Counsel
    Planned sale
    $208K 1,580 shares at $131.49 3.3% of stake
    Traded Feb 20 Filed Feb 23
    ↗

Also filed in the last 12 months, not counted as buying or selling: 29 stock grants, 23 share withholdings for taxes, and 18 option exercises.

Congress

2 members of Congress traded ENTG in the last three years: 12 buys and 7 sales. 1 member listed it in 2025 annual reports.

All Congress trades
  1. April McClain Delaney D-MD-6Child Sell $100K–$250K Aug 25 filed Sep 9
  2. April McClain Delaney D-MD-6Child Buy $1K–$15K Jul 30 filed Aug 3
  3. April McClain Delaney D-MD-6Child Buy $1K–$15K Jul 8 filed Aug 3
  4. April McClain Delaney D-MD-6Child Buy $1K–$15K Jun 8 filed Jul 7
  5. April McClain Delaney D-MD-6Child Buy $1K–$15K Jun 5 filed Jul 7
  6. April McClain Delaney D-MD-6Child Buy $1K–$15K May 21 filed Jun 5

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
8-K 8.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02 Filing Doc
8-K 5.03,5.07,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 8.01 Filing Doc

Source: SEC EDGAR submissions, updated about 16 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $3.52B $3.24B $3.2B
Gross profit $1.5B $1.49B $1.42B
Gross margin * 42.5% 45.9% 44.4%
Net income $180.67M $292.79M $235.6M
Net margin * 5.1% 9.0% 7.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.98B $1.62B $1.64B
Total non-current assets * $6.84B $6.78B $6.71B
Total assets $8.81B $8.39B $8.35B
Total current liabilities $514M $525.18M $488.6M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $629.56M $631.72M $695.4M
Cash from investing $553.07M -$67.08M -$300.8M
Cash from financing -$1.28B -$0.689B -$0.367B
Net change in cash -$106.51M -$127.72M $31.2M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.